首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Therapeutic advances in psychopharmacology

缩写:

ISSN:2045-1253

e-ISSN:2045-1261

IF/分区:4.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引606
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Roger S McIntyre,Pedro Such,Murat Yildirim et al. Roger S McIntyre et al.
The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formu...
Thomas Messer,Miquel Bernardo,Lourdes Anta et al. Thomas Messer et al.
One of the most important challenges in the management of patients with schizophrenia is to ensure adherence to antipsychotic treatment. The contribution of long-acting injectables (LAI) is undeniable in this matter, but there are still som...
Carol Paton,Paul Bassett,Olivia Rendora et al. Carol Paton et al.
Background: Optimal use of lithium involves adjustment of the dose, to keep the plasma level within the narrow, recommended range. Brand-specific prescribing has long been considered critical to achieving this aim, but th...
Che Jiang,Yong Yang,Lili Wu et al. Che Jiang et al.
Background: Repetitive transcranial magnetic stimulation (rTMS) showed potentially beneficial effects for the treatment of post-traumatic stress disorder (PTSD). Low-frequency (LF) rTMS decreases neuronal excitability and...
Rebecca Henry,David S Baldwin Rebecca Henry
Background: The benefit of generalist pharmacists working within primary care networks (PCNs) and with general practitioners (GPs) is established. We wished to evaluate the contributions and potential benefits of a specia...
James R O&#x;Neill,David M Taylor,Mark A Horowitz James R O&#x;Neill
Background: Reducing the dose of psychosis drugs in a gradual hyperbolic manner may minimise withdrawal effects and risk of relapse. There is presently limited guidance on tapering decanoate-based long-acting injectable d...
Baeleigh VanderZwaag,Albert Garcia-Romeu,Mauricio A Garcia-Barrera Baeleigh VanderZwaag
Background: Psychedelics are receiving growing interest among clinical researchers for their effects on mood and cognition. Psilocybin is one of the most widely studied classic psychedelics which has shown good safety and...